Table 1:

Demographic and clinical dataa

Pre-HD ControlsPre-HD SubjectsHD ControlsHD Patients (Stage I)
Number of subjects1415119
Age (yr)31 ± 6.732 ± 6.649.7 ± 13.546.7 ± 8.5
Sex (M:F)5:97:85:67:2
CAG repeats, expanded allele42.6 ± 3.145.1 ± 2.8
TFC score1311.8 ± 1.4
Disease duration (yr)3.9 ± 3.6
UHDRS score17.3 ± 3.9
  • a Values are expressed as mean ± SD.